Lombard raises up to $3.9 million:
This article was originally published in Clinica
UK company Lombard Medical has raised up to £2.5m ($3.9m), with a £2m pledged by private equity firm Camden Partners. The US equity firm may also subscribe to a further £300,000, Lombard says. The company is aiming the funds at developing cardiovascular products, a market which was estimated at £13bn in 2001. The market is forecast to grow to £20.4bn in 2004, the London-based company says. "I am delighted to be able to announce the success of the fund raising achieved in a very difficult market where many companies were postponing or cancelling their fundraising activities," said Alistair Taylor, Lombard's chairman.
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.